EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 24 filers reported holding EVOGENE LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $152,000 | -15.6% | 86,734 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $180,000 | -30.2% | 86,734 | 0.0% | 0.01% | -42.9% |
| Q3 2018 | $258,000 | +3.6% | 86,734 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $249,000 | -8.5% | 86,734 | 0.0% | 0.02% | -41.7% |
| Q1 2018 | $272,000 | -3.9% | 86,734 | 0.0% | 0.04% | -10.0% |
| Q4 2017 | $283,000 | – | 86,734 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MOON CAPITAL MANAGEMENT LP | 280,675 | $331,000 | 0.31% |
| Senvest Management, LLC | 414,682 | $489,000 | 0.06% |
| Clal Insurance Enterprises Holdings Ltd | 591,264 | $698,000 | 0.02% |
| Phoenix Holdings Ltd. | 263,133 | $303,000 | 0.02% |
| WADDELL & REED FINANCIAL INC | 2,757,203 | $3,226,000 | 0.01% |
| ARK Investment Management | 256,129 | $302,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 19,717 | $23,000 | 0.00% |
| JPMORGAN CHASE & CO | 220,373 | $3,662,000 | 0.00% |
| UBS Group AG | 1,357,260 | $1,602,000 | 0.00% |
| BARCLAYS PLC | 696 | $1,000 | 0.00% |